External consultants are members of the Scientific Committee of the Foundation and they are directly involved in the study and research of the disease:
Dr. CECILIA JIMENEZ MALLABRERA
Laboratory of Applied Research on Children Neuromuscular Diseases.Neuromuscular Pathology Unit. Dept. of Pediatric Neurology. Sant Joan de DeuUniversity Hospital, Barcelona.
Dr. NASCIMENTO ANDRES OSORIO
Neuromuscular Pathology Unit, Department of Neurology, Sant Joan de DeuUniversity Hospital, Barcelona.
Dr. ANNE RUTKOWSKI
Co-Founder and Former Chairman of Cure CMD (2009-2012), she oversees the annual Cure CMD grant program, scientific conferences, biobanks, registry and visits local clinics.
Anne works with clinicians and scientists worldwide to support current CMD research and evaluate opportunities for the CMDIR patients to participate in clinical research. Dr. Rutkowski is a practicing, board certified emergency medicine physician in Los Angeles.
Dr. Rutkowski’s daughter has congenital muscular dystrophy, dystroglycanopathy subtype.
Dr. Rutkowski graduated from the University of California Irvine Medical Schooland was elected to Alpha Omega Alpha Honor Medical Society. She attended Bryn Mawr College as an undergraduate, graduating Magna cum laude with Honors in Biology. Prior to attending medical school, Dr. Rutkowski taught for 3 years in an inner city elementary school in Los Angeles, as part of Teach for America.
She would like to shrink the diagnostic odyssey, see improvements and standardization of guidelines in medical care for all patients with CMD,and a focused approach to identifying therapeutic targets. As a former teacher, education and improved disease awareness are two further areas of focus for Cure CMD.
Dr. GUSTAVO DZIEWCZAPOLSKI, PhD
He got his Biology degree at the University of Buenos Aires, Argentina in 1991, where he continued his scientific training to get his PhD in Neuropharmacology in 1998.
He then moved to the United States to continue his scientific career at the University of California, San Diego, leading stem cells research projects in animal models of Parkinson’s disease. In 2003 he joined the Salk Institute to engage in research projects on therapeutic targets for Alzheimer’s disease. He has so far published 20 scientific papers that have been cited over 2,000 times.
Ever since September 2016, Dr. Dziewczapolski began a new chapter in his career as Scientific Director of Cure CMD. In his new role, he oversees the annual grant program of the Cure CMD Foundation, focused on finding treatments for the entire range of congenital muscular dystrophies, organizes and participates in scientific conferences in the same field and aims to become a link between patients and their families, regulatory bodies that assess new treatments and the medical and scientific community that researches, tests and designs therapies to improve the quality of life and, eventually, find a cure.
Gustavo is proud dad of two beautiful girls, Tatiana (11) and Rafaela (8), who inspire and energize him every day. And to balance his addiction to chocolate, he surfs and plays soccer in his spare time.